Skip to main content

Medial Temporal Lobectomy Aids Seizure Outcomes in Epilepsy

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on April 14, 2025.

via HealthDay

MONDAY, April 14, 2025 -- Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe epilepsy, according to a study published online March 6 in Cureus.

In a prospective cohort interventional study conducted in Egypt between 2022 and 2024, Sameh M. Salama, Ph.D., from the Al-Azhar University of Medicine in Cairo, and colleagues assessed epilepsy control after medial temporal lobectomy (with or without amygdalohippocampectomy) for management of drug-resistant temporal lobe epilepsy. Postoperative seizure control was evaluated using the Engel classification scale during follow-up and withdrawal of antiepileptic drugs.

The researchers found that seizure control improved after medial temporal lobectomy. At final follow-up, 15 respondents (75 percent) reached Engel class I (no seizures) and five respondents (25 percent) reached Engel class II (rare, nondisabling seizures).

"These results support surgical management as an essential treatment option for medically refractory epilepsy and highlight the importance of identifying patients for early surgical evaluation," Salama and colleagues conclude. "More studies with bigger sample sizes along with extended follow-up periods should be performed to improve patient selection criteria and surgical methods that enhance patient outcomes."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Epilepsy More Common With Frontotemporal Dementia

TUESDAY, June 10, 2025 -- Epilepsy is more common among those with frontotemporal dementia (FTD) than among people with Alzheimer disease (AD) or healthy controls, according to a...

Tumor-Related Epilepsy Not Strong Prognostic Factor in Diffuse Glioma

WEDNESDAY, May 21, 2025 -- For patients with diffuse gliomas, tumor-related epilepsy (TRE) is not a strong prognostic factor, according to a study published in the May issue of...

All-Cause Mortality Higher With Sleep Deprivation in Seniors With Epilepsy

MONDAY, May 19, 2025 -- Older adults with sleep deprivation and epilepsy have an elevated risk for all-cause mortality, according to a study published online April 23 in...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.